AbbVie CEO Robert Michael will soon add the role of board chairman to his résumé. Michael, who became CEO of the North Chicago-based pharmaceutical giant last summer, will assume duties as ...

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform.

"At Neomorph, we have spent years building a unique molecular glue platform ... "We are thrilled to partner with AbbVie, a global leader in delivering transformative medicines in oncology and ...